Palas Paul
About Palas Paul
Data last updated:
Palas Paul is a Director at La Revas Pharma Private Limited (since 2018). The company operates in FMCG. La Revas Pharma Private Limited reported revenue of ₹63.8 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 La Revas Pharma Private Limited U74999MH2018PTC313802 | Director | 10 Sep 2018 | 2018 | ₹63.8 Lakh (FY 2023) | Active |
Board colleagues of Palas Paul
| Name | DIN | Company | Designation |
|---|---|---|---|
| Biplab Nandi | 03153490 | La Revas Pharma Private Limited | Director |
| Sandipan Chakraborty | 03153481 | La Revas Pharma Private Limited | Director |
| Sujoy Mitra | 03153488 | La Revas Pharma Private Limited | Director |
| Syed Asif Ali | 03132701 | La Revas Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Palas Paul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Palas Paul
Palas Paul currently holds 1 directorship: La Revas Pharma Private Limited (Director, since 10 Sep 2018, revenue ₹63.8 Lakh (FY 2023)).
Palas Paul was first appointed on 10 Sep 2018 as Director at La Revas Pharma Private Limited.
The current boards of Palas Paul's companies include Biplab Nandi (La Revas Pharma Private Limited), Sandipan Chakraborty (La Revas Pharma Private Limited), Sujoy Mitra (La Revas Pharma Private Limited), Syed Asif Ali (La Revas Pharma Private Limited).